Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Dramatic elevation in urinary amino terminal titin fragment excretion quantified by immunoassay in Duchenne muscular dystrophy patients and in dystrophin deficient rodents.

Robertson AS, Majchrzak MJ, Smith CM, Gagnon RC, Devidze N, Banks GB, Little SC, Nabbie F, Bounous DI, DiPiero J, Jacobsen LK, Bristow LJ, Ahlijanian MK, Stimpson SA.

Neuromuscul Disord. 2017 Jul;27(7):635-645. doi: 10.1016/j.nmd.2017.05.009. Epub 2017 May 12.

2.

Proteome-wide muscle protein fractional synthesis rates predict muscle mass gain in response to a selective androgen receptor modulator in rats.

Shankaran M, Shearer TW, Stimpson SA, Turner SM, King C, Wong PY, Shen Y, Turnbull PS, Kramer F, Clifton L, Russell A, Hellerstein MK, Evans WJ.

Am J Physiol Endocrinol Metab. 2016 Mar 15;310(6):E405-17. doi: 10.1152/ajpendo.00257.2015. Epub 2015 Dec 29.

3.

Genetic Ablation of CD38 Protects against Western Diet-Induced Exercise Intolerance and Metabolic Inflexibility.

Chiang SH, Harrington WW, Luo G, Milliken NO, Ulrich JC, Chen J, Rajpal DK, Qian Y, Carpenter T, Murray R, Geske RS, Stimpson SA, Kramer HF, Haffner CD, Becherer JD, Preugschat F, Billin AN.

PLoS One. 2015 Aug 19;10(8):e0134927. doi: 10.1371/journal.pone.0134927. eCollection 2015.

4.

Total body skeletal muscle mass: estimation by creatine (methyl-d3) dilution in humans.

Clark RV, Walker AC, O'Connor-Semmes RL, Leonard MS, Miller RR, Stimpson SA, Turner SM, Ravussin E, Cefalu WT, Hellerstein MK, Evans WJ.

J Appl Physiol (1985). 2014 Jun 15;116(12):1605-13. doi: 10.1152/japplphysiol.00045.2014. Epub 2014 Apr 24.

5.

Post-transcriptional regulation of ITGB6 protein levels in damaged skeletal muscle.

Ducceschi M, Clifton LG, Stimpson SA, Billin AN.

J Mol Histol. 2014 Jun;45(3):329-36. doi: 10.1007/s10735-014-9567-2. Epub 2014 Feb 2.

6.

Longitudinal changes in total body creatine pool size and skeletal muscle mass using the D3-creatine dilution method.

Stimpson SA, Leonard MS, Clifton LG, Poole JC, Turner SM, Shearer TW, Remlinger KS, Clark RV, Hellerstein MK, Evans WJ.

J Cachexia Sarcopenia Muscle. 2013 Jun 25. [Epub ahead of print]

7.

Total-body creatine pool size and skeletal muscle mass determination by creatine-(methyl-D3) dilution in rats.

Stimpson SA, Turner SM, Clifton LG, Poole JC, Mohammed HA, Shearer TW, Waitt GM, Hagerty LL, Remlinger KS, Hellerstein MK, Evans WJ.

J Appl Physiol (1985). 2012 Jun;112(11):1940-8. doi: 10.1152/japplphysiol.00122.2012. Epub 2012 Mar 15.

8.

Effectiveness of the PPARγ agonist, GW570, in liver fibrosis.

Yang L, Stimpson SA, Chen L, Wallace Harrington W, Rockey DC.

Inflamm Res. 2010 Dec;59(12):1061-71. doi: 10.1007/s00011-010-0226-0. Epub 2010 Jun 29.

PMID:
20585829
9.

The identification of pyrazolo[1,5-a]pyridines as potent p38 kinase inhibitors.

Cheung M, Harris PA, Badiang JG, Peckham GE, Chamberlain SD, Alberti MJ, Jung DK, Harris SS, Bramson NH, Epperly AH, Stimpson SA, Peel MR.

Bioorg Med Chem Lett. 2008 Oct 15;18(20):5428-30. doi: 10.1016/j.bmcl.2008.09.040. Epub 2008 Sep 12.

PMID:
18818075
10.

RU486 did not exacerbate cytokine release in mice challenged with LPS nor in db/db mice.

Yang B, Trump RP, Shen Y, McNulty JA, Clifton LG, Stimpson SA, Lin P, Pahel GL.

BMC Pharmacol. 2008 May 12;8:7. doi: 10.1186/1471-2210-8-7.

11.

Effects of the cFMS kinase inhibitor 5-(3-methoxy-4-((4-methoxybenzyl)oxy)benzyl)pyrimidine-2,4-diamine (GW2580) in normal and arthritic rats.

Conway JG, Pink H, Bergquist ML, Han B, Depee S, Tadepalli S, Lin P, Crumrine RC, Binz J, Clark RL, Selph JL, Stimpson SA, Hutchins JT, Chamberlain SD, Brodie TA.

J Pharmacol Exp Ther. 2008 Jul;326(1):41-50. doi: 10.1124/jpet.107.129429. Epub 2008 Apr 23.

PMID:
18434589
12.

PPARgamma agonists prevent TGFbeta1/Smad3-signaling in human hepatic stellate cells.

Zhao C, Chen W, Yang L, Chen L, Stimpson SA, Diehl AM.

Biochem Biophys Res Commun. 2006 Nov 17;350(2):385-91. Epub 2006 Sep 22.

13.

Regulation of peroxisome proliferator-activated receptor-gamma in liver fibrosis.

Yang L, Chan CC, Kwon OS, Liu S, McGhee J, Stimpson SA, Chen LZ, Harrington WW, Symonds WT, Rockey DC.

Am J Physiol Gastrointest Liver Physiol. 2006 Nov;291(5):G902-11. Epub 2006 Jun 22.

14.

Changes of skeletal muscle adiponectin content in diet-induced insulin resistant rats.

Yang B, Chen L, Qian Y, Triantafillou JA, McNulty JA, Carrick K, Clifton LG, Han B, Geske R, Strum J, Brown KK, Stimpson SA, Pahel G.

Biochem Biophys Res Commun. 2006 Mar 3;341(1):209-17. Epub 2006 Jan 9.

PMID:
16414018
15.

PPARgamma agonists diminish serum VEGF elevation in diet-induced insulin resistant SD rats and ZDF rats.

Yang B, Lin P, Carrick KM, McNulty JA, Clifton LG, Winegar DA, Strum JC, Stimpson SA, Pahel GL.

Biochem Biophys Res Commun. 2005 Aug 19;334(1):176-82.

PMID:
15993383
16.

Phosphorylation of p70s6 kinase is implicated in androgen-induced levator ani muscle anabolism in castrated rats.

Xu T, Shen Y, Pink H, Triantafillou J, Stimpson SA, Turnbull P, Han B.

J Steroid Biochem Mol Biol. 2004 Dec;92(5):447-54. Epub 2004 Dec 21.

PMID:
15698549
17.

Serum adiponectin as a biomarker for in vivo PPARgamma activation and PPARgamma agonist-induced efficacy on insulin sensitization/lipid lowering in rats.

Yang B, Brown KK, Chen L, Carrick KM, Clifton LG, McNulty JA, Winegar DA, Strum JC, Stimpson SA, Pahel GL.

BMC Pharmacol. 2004 Oct 18;4:23.

18.

GI262570, a peroxisome proliferator-activated receptor {gamma} agonist, changes electrolytes and water reabsorption from the distal nephron in rats.

Chen L, Yang B, McNulty JA, Clifton LG, Binz JG, Grimes AM, Strum JC, Harrington WW, Chen Z, Balon TW, Stimpson SA, Brown KK.

J Pharmacol Exp Ther. 2005 Feb;312(2):718-25. Epub 2004 Oct 8.

PMID:
15475592
19.

CD14 mediates the innate immune responses to arthritopathogenic peptidoglycan-polysaccharide complexes of Gram-positive bacterial cell walls.

Li X, Bradford BU, Dalldorf F, Goyert SM, Stimpson SA, Thurman RG, Makarov SS.

Arthritis Res Ther. 2004;6(3):R273-81. Epub 2004 Apr 27.

20.

Inhibition of tumor necrosis factor-alpha (TNF-alpha) production and arthritis in the rat by GW3333, a dual inhibitor of TNF-alpha-converting enzyme and matrix metalloproteinases.

Conway JG, Andrews RC, Beaudet B, Bickett DM, Boncek V, Brodie TA, Clark RL, Crumrine RC, Leenitzer MA, McDougald DL, Han B, Hedeen K, Lin P, Milla M, Moss M, Pink H, Rabinowitz MH, Tippin T, Scates PW, Selph J, Stimpson SA, Warner J, Becherer JD.

J Pharmacol Exp Ther. 2001 Sep;298(3):900-8.

PMID:
11504783
21.

Dietary glycine prevents peptidoglycan polysaccharide-induced reactive arthritis in the rat: role for glycine-gated chloride channel.

Li X, Bradford BU, Wheeler MD, Stimpson SA, Pink HM, Brodie TA, Schwab JH, Thurman RG.

Infect Immun. 2001 Sep;69(9):5883-91.

22.

NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint.

Miagkov AV, Kovalenko DV, Brown CE, Didsbury JR, Cogswell JP, Stimpson SA, Baldwin AS, Makarov SS.

Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13859-64.

23.

Targeting of SCG10 to the area of the Golgi complex is mediated by its NH2-terminal region.

Di Paolo G, Lutjens R, Pellier V, Stimpson SA, Beuchat MH, Catsicas S, Grenningloh G.

J Biol Chem. 1997 Feb 21;272(8):5175-82.

24.

Regulation of microtubule dynamics by the neuronal growth-associated protein SCG10.

Riederer BM, Pellier V, Antonsson B, Di Paolo G, Stimpson SA, Lütjens R, Catsicas S, Grenningloh G.

Proc Natl Acad Sci U S A. 1997 Jan 21;94(2):741-5.

25.

Inhibition of cartilage and bone destruction in adjuvant arthritis in the rat by a matrix metalloproteinase inhibitor.

Conway JG, Wakefield JA, Brown RH, Marron BE, Sekut L, Stimpson SA, McElroy A, Menius JA, Jeffreys JJ, Clark RL, et al.

J Exp Med. 1995 Aug 1;182(2):449-57.

26.

Anti-inflammatory activity of phosphodiesterase (PDE)-IV inhibitors in acute and chronic models of inflammation.

Sekut L, Yarnall D, Stimpson SA, Noel LS, Bateman-Fite R, Clark RL, Brackeen MF, Menius JA Jr, Connolly KM.

Clin Exp Immunol. 1995 Apr;100(1):126-32.

27.

Differential regulation of human monocyte-derived TNF alpha and IL-1 beta by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors.

Verghese MW, McConnell RT, Strickland AB, Gooding RC, Stimpson SA, Yarnall DP, Taylor JD, Furdon PJ.

J Pharmacol Exp Ther. 1995 Mar;272(3):1313-20.

PMID:
7891349
28.

Regulation of cytokines workshop.

Stimpson SA, Stevens P.

Agents Actions Suppl. 1993;41:195-9. No abstract available.

PMID:
8100391
29.
30.

Flare-up reaction of streptococcal cell wall induced arthritis in Lewis and F344 rats: the role of T lymphocytes.

van den Broek MF, van Bruggen MC, Stimpson SA, Severijnen AJ, van de Putte LB, van den Berg WB.

Clin Exp Immunol. 1990 Feb;79(2):297-306.

31.

Exacerbation of arthritis by IL-1 in rat joints previously injured by peptidoglycan-polysaccharide.

Stimpson SA, Dalldorf FG, Otterness IG, Schwab JH.

J Immunol. 1988 May 1;140(9):2964-9.

PMID:
3283241
32.

Lipopolysaccharide induces recurrence of arthritis in rat joints previously injured by peptidoglycan-polysaccharide.

Stimpson SA, Esser RE, Carter PB, Sartor RB, Cromartie WJ, Schwab JH.

J Exp Med. 1987 Jun 1;165(6):1688-702.

33.

Effect of acetylation on arthropathic activity of group A streptococcal peptidoglycan-polysaccharide fragments.

Stimpson SA, Lerch RA, Cleland DR, Yarnall DP, Clark RL, Cromartie WJ, Schwab JH.

Infect Immun. 1987 Jan;55(1):16-23.

34.
35.

Comparison of inflammatory reactions induced by intraarticular injection of bacterial cell wall polymers.

Esser RE, Anderle SK, Chetty C, Stimpson SA, Cromartie WJ, Schwab JH.

Am J Pathol. 1986 Feb;122(2):323-34.

36.

Arthropathic properties of cell wall polymers from normal flora bacteria.

Stimpson SA, Brown RR, Anderle SK, Klapper DG, Clark RL, Cromartie WJ, Schwab JH.

Infect Immun. 1986 Jan;51(1):240-9.

37.

Reactivation of streptococcal cell wall-induced arthritis by homologous and heterologous cell wall polymers.

Esser RE, Stimpson SA, Cromartie WJ, Schwab JH.

Arthritis Rheum. 1985 Dec;28(12):1402-11.

PMID:
3910050
38.

Observations on the nature of the determinants in anaerobic coryneforms which produce splenomegaly.

Cummins CS, Stimpson SA, Tuttle RL, Weck CJ.

J Reticuloendothel Soc. 1981 Jan;29(1):1-13. No abstract available.

PMID:
6259348

Supplemental Content

Loading ...
Support Center